ABBV - AbbVie: Dividend Is Safe
Somewhat unnoticed in the stock action following the AbbVie (ABBV) deal to purchase Allergan (AGN) was the surging yield of the acquiring stock. The size and scale of the debt load from the deal caused investors to panic, but AbbVie is a bargain now as the dividend yield surged 6.5%.
Image Source: AbbVie website
Allergan Debt
On Tuesday, AbbVie announced plans to acquire Allergan in a cash and stock deal. The owner of Botox comes with a heavy debt load so investors naturally have concerns about the large dividend of AbbVie